Power Law company profile

Immunovant’s

Biotech & Life Sciences · New York City, United States · Founded 2018 · IPO 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$4.77B

Market cap · Apr/2026

Investors

4 investors on Immunovant’s's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Global footprint

Web traffic by country

6.7K monthly visits
across markets

🇺🇸 United States73.1%

🇮🇳 India16.4%

🇬🇧 United Kingdom7.5%

🇨🇦 Canada1.5%

🇧🇪 Belgium1.5%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo